A 60-second, daily summary of the most important data on COVID-19 in the U.S., updated every morning.
Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer on how various countries have handled the COVID-19 pandemic and safety parameters for children returning to school.
The National Institutes of Health announced the start of two clinical trials for a potential coronavirus treatment called monoclonal antibodies.
Testing per capita has declined steadily in at least six states over the last two weeks. Meanwhile, test positivity rates have risen in 32 states during the same time frame, according to data from Johns Hopkins University.
Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses the global surge in coronavirus cases, locations returning to lockdowns, and concerns about what happens with the virus in the colder weather months.
Dr. Arturo Casadevall, a microbiologist and physician at Johns Hopkins University, has spearheaded a nationwide initiative to test the healing powers of “convalescent plasma” from COVID-19 survivors.
Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz on coronavirus vaccine trials, an increase in Covid-19 mortality rates, and questions surrounding the return of children to school in the fall.
Experts from the Infectious Diseases Society of America and Johns Hopkins Center for Health Security on what we know about kids and COVID-19.
Inadequate testing and protracted delays in producing results have crippled tracking and hampered efforts to contain major outbreaks in the U.S.
A new study suggests that the immune systems of some people who have not been exposed to the novel coronavirus could have some familiarity with the pathogen.
The colossal impact of the coronavirus is motivating the speed for prospective vaccines, opening a spigot of funding and inspiring research teams around the world to join the hunt.
To assess where the country is heading now, The New York Times interviewed 20 public health experts — not just clinicians and epidemiologists, but also historians and sociologists, because the spread of coronavirus is now influenced as much by human behavior as it is by the pathogen itself.
This brief report from the Center for Health Security at Johns Hopkins Bloomberg School of Public Health describes concrete policy actions at the federal, state, and local levels that are needed to get control of the COVID-19 pandemic in the United States.
Although the ideal COVID-19 vaccine would completely prevent infection, a shot that reduces severe illness and mortality is still a success.